Schroder Investment Management Group grew its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 19.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 488,451 shares of the medical research company’s stock after buying an additional 79,919 shares […]